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Intelligent data analysis in biomedicine1. Introduction
Data are ubiquitous in biomedicine. In the domain of
clinical care, information systems longitudinally capture
and store hundreds of data elements for each patient at
each outpatient encounter and inpatient hospitalization.
Sources of these data include diagnostic as well as thera-
peutic services. Patient data management systems in oper-
ating theaters and intensive care units even collect
megabytes of monitoring data during a single day. New
three-dimensional digital imaging techniques have created
vast arrays of patient data, the potential of which is largely
yet to be explored. In molecular biology, the emergence of
high-throughput DNA sequencing technology has created
new, rich sources of genomic information.
Data have also bourgeoned in clinical and basic research
facilities and laboratories. The increasing use of advanced
assay methods in genomic, proteomic, and metabolomic
studies and high-performance database architectures for
research data capture, storage, and analysis has resulted in the
availability of unprecedented amounts of data. This develop-
ment aﬀects virtually every region of the clinical and basic
research domain, and stresses the importance of transla-
tional research. This is reﬂected by new funding initiatives
such as the National Institutes of Health’s Roadmap and
Clinical Translational Science Award (CTSA) programs.
This increase in the amount and availability of data in
clinical care and research settings carries a concomitant bur-
den: the eﬀective, eﬃcient, and accurate analysis of these
data. Traditional statistical methods, such as linear, logistic,
and Cox regression modeling, have served us well over the
years, and continue to do so. They constitute the founda-
tional analytical toolkit for those working in clinical care,
research, and healthcare administration, even as new statis-
tical tools continue to be developed and ﬁnd their way into
mainstream use in these domains [1]. However, statistical
methods rely on specialized knowledge and skills of analysts,
and require them to carry out a large number of manual
operations. As a result, a ‘‘data gap’’ is caused by the widen-
ing gulf between the amount of biomedical data and the
number and skills of those who would analyze such data
[2,3]. In addition, the sheer size of today’s biomedical data
collections often causes problems for traditional statistical1532-0464/$ - see front matter  2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.jbi.2007.10.001methods. Thesematters inform the purpose and focus of this
special issue of the Journal of Biomedical Informatics on
intelligent data analysis in biomedicine.
Intelligent data analysis (IDA) can be deﬁned as the use of
specialized statistical, pattern recognition,machine learning,
data abstraction, and visualization tools for analysis of data
and discovery of mechanisms that created the data [2]. Such
data are typically complex, meaning that they are character-
ized by many records, many variables, subtle interactions
between variables, or a combination of all three. In addition,
variable-value domainsmaybe expressed inways that depart
from the traditional nominal–ordinal–interval-ratio hierar-
chy, such as log scale or model-based representations. Final-
ly, and especially with the evolution of translational
research, biomedical data are becoming increasingly hetero-
geneous, with clinical observation and measurement data
merged with genomic or proteomic data in the same record.
All of these contribute to a complex data landscape that is
often diﬃcult if not impossible to analyze without the use
of IDA-based tools. The 15 papers in this issue provide a
strong and ‘‘cutting-edge’’ representation of these tools
and their applications.
Before we review the themes that emerge from the papers
in this issue, we must ﬁrst address the relationships of IDA
with its close relatives, knowledge discovery in databases
and data mining. Knowledge discovery in databases
(KDD) is best thought of as a processwhere the data are used
for hypothesis generation rather than hypothesis testing (as
in traditional statistical analysis). It is conducted within a
lifecycle framework that includes data cleaning, data prepa-
ration, model building, model evaluation, visualization, and
reporting [4–6]. The process of KDD is structured around
this framework to provide an overarching analytic method-
ology and to avoid a ‘‘ﬁshing expedition’’. Certainly,
hypothesis testing is often used in KDD, but is generally
restricted to exploration of the data or the comparative eval-
uation of twoormore analytic tools. Thus, point estimates of
chi-square values and t-statistics, along with p-values and
conﬁdence intervals, will often be reported in a KDD analy-
sis, but not as deﬁnitive indicators of association or implied
causation. Thesewould be left to the application of statistical
methods in amore traditional analysis, whichmay have been
informed by a KDD analysis.
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teristic that distinguishes KDD from traditional statistical
analysis is the use of diﬀerent methods from the disciplines
of pattern recognition and signal detection, statistics, and
machine learning. Although sometimes the terms are used
interchangeably, KDD is not the same as data mining, which
is the applicationof specialized tools to assist with the process
of KDD. More precisely, data mining is the application of
specialized software tools to the analysis of large data sets
to ﬁnd unsuspected relationships and to summarize the data
in novel ways that are both understandable and useful to the
owner [7]. IDA is closely related to data mining, but uses
prior domain knowledge to guide the analysis, often in an
interactive and iterative fashion. Using prior knowledge
not only increases the eﬃciency of the knowledge discovery
process, but also helps to avoid reporting trivial results to
the end-user. IDA uses many of the same methods used in
traditional analysis, but also includes statistical classiﬁers
such as support vector machines and hidden Markov mod-
els, probabilistic methods such as Bayesian classiﬁers and
belief networks, nature-inspired methods such as neural net-
works, genetic algorithms, and artiﬁcial immune systems, as
well as tree-building and rule-discovery methods. Many of
these are represented in this special issue.
In the biomedical ﬁeld, IDA emerged in the late 1980s
from a quest for objective knowledge sources that could
replace the traditional ‘expert’ in the development of rule-
based systems [3]. Subjectively deﬁned rules may mirror
the psychological biases that are common to everyday hu-
man reasoning. Furthermore, expert rule bases were often
found to be inconsistent and incomplete despite the fact
the individual rules appeared to be correct. For these rea-
sons, the learning of rules from data that were gathered in
the daily practice of experts and stored systematically in dat-
abases became appealing as a more reliable source of knowl-
edge. Within this approach, experts obtained a diﬀerent role
than before, providing background knowledge for focusing
and guiding the learning process. With the increasing vol-
umes of data that are today being captured in clinical prac-
tice and biomedical research, the emphasis of IDA has
shifted from knowledge-based systems engineering to the
more general task of interpreting data in an ‘‘intelligent’’
way. What has remained unchanged, however, is the central
role of knowledge in the data analysis process: IDA uses
knowledge and data to discover new knowledge.
By way of introduction to the papers in this issue, we
have considered two important dimensions of IDA: meth-
ods and applications. Each of these dimensions in turn has
its own set of themes that emerge from the papers, and we
discuss these here.
2. Methods of IDA
2.1. Dimensionality reduction and feature subset selection
There are numerous methodologic approaches to IDA
that are reﬂected in the themes within which the papersin this issue coalesce. The KDD life cycle provides a con-
ceptual framework for considering these approaches. The
ﬁrst step in this life cycle is data cleaning and preparation,
which frequently involves the reduction of the dimensional
complexity of a dataset. When we talk about the complex-
ity of biomedical data, we are often actually thinking about
their dimensionality and, in turn, ways to reduce it so that
we can discover meaningful (i.e., understandable) knowl-
edge. Feature subset selection is an essential component of
this reduction process and is represented in this issue by
several papers.
Panteris et al. [8] describe a new methodology for fea-
ture selection using metabolic pathways and prior domain
knowledge to create ‘‘pathway signatures’’ as an approach
to dimensionality reduction in microarray data. Mahata
and Mahata [9] report on a method for selecting subsets
of predictive genes from thousands of candidates ranked
by minimum probability of classiﬁcation error. The novelty
in their work is that these probabilities are computed by
non-parametric density estimation. Nayak and De [10] also
investigate reducing the complexity of signaling pathway
information, but through the use of a new modularization
algorithm.
2.2. Data exploration
Exploring a dataset is an important prelude to building
models for classiﬁcation and prediction; it is the component
of the KDD life cycle where most knowledge discovery actu-
ally takes place. There is a critical need for the development
and application of software tools that facilitate accurate
knowledge discovery through user-directed exploration.
These tools provide users the opportunity to interact with
them, so that they have some sense of input into the explora-
tion process; they stand in contradistinction to purely auto-
mated exploration tools that leave users out of that process.
The incorporation of user-deﬁned knowledge and user inter-
action in data exploration is a hallmarkof the IDA-based ap-
proach to KDD. One family of such exploration tools relies
on visualization of relationships between features, between
values of features, and between features and classes. Demsar
et al.’s paper [11] is an example of the kind of work that is
being done in data visualization that goes beyond traditional
graphical methods such as histograms and scatterplots.
Demsar et al. present a tool, FreeViz, that facilitates the hu-
man comprehension of highly complex classiﬁcation data,
by visual exploration of multidimensional feature interac-
tions. These are often unexpected, but common in biomedi-
cal data. A second paper (Lessmann et al. [12]) describes a
method for visualizing complex histopathological image fea-
tures, informed by human expert knowledge in order to ex-
tract information from the image that is both meaningful
and relevant. Finally, Dinu et al. [13] report on a new tool,
Pathway/SNP, which is designed to help users explore the
association between biomolecular pathways and disease by
integrating domain knowledge with statistical and data min-
ing algorithms.
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take place at a particular moment in, or over some period
of time [14]. It is thus appropriate that a number of papers
in this issue investigate the development and evaluation of
methods and tools for time-series or temporal data explo-
ration. One particular challenge in this context is the
extraction of temporal patterns that are both relevant for
the application domain at hand and meaningful for users.
Guyet et al. [15] address this challenge by using a multi-
agent collaborative learning framework that incorporates
human input to analyze multivariate time-series data.
Agent-based autonomy, adaptability, and emergence
provide the foundation for the framework, and this work
represents one of the ﬁrst investigations of multi-agent
technology in IDA. The paper by Sacchi et al. [16] also
focuses on time-series data analysis but from the perspec-
tive of temporal abstraction. Sacchi et al. use data to create
Precedence Temporal Networks, a novel, graph-based
approach to visualization of temporal precedence relations.
Wallstrom and Hogan [17] consider the discovery of aggre-
gates from time series data, but using an unsupervised
learning approach that incorporates Markov Chain Monte
Carlo simulation to estimate the parameters in complex
Bayesian clustering models.
2.3. Classiﬁcation and prediction
While data exploration and visualization are essential
elements of IDA, the development of useful and accurate
models for classiﬁcation and prediction represents the
potential for applying IDA to real-world problems in basic
medical and clinical research and ultimately clinical prac-
tice. Several papers in this issue report on the development
and evaluation of IDA tools for classiﬁcation and predic-
tion. The two papers by Verduijn et al. [18,19] describe a
novel predictive modeling method that employs a Bayesian
network composed of a collection of local supervised learn-
ing models, which are in turn recursively learned from the
data. An interaction layer ensures that clinicians can use
the tool in real-world settings to determine patient progno-
sis. Wang [20] also applies probabilistic graphical models
for prediction, but now in the genomic domain for the dis-
covery of interactions between genes and transcription
factors.
Support vector machines (SVMs) have been used with
some frequency in genomics, but less so in clinical
domains. Matheny et al. [21] investigate four methods
for optimizing parameters for two diﬀerent kernel SVMs
when applied to a clinical problem, the prediction of mor-
tality in percutaneous coronary interventions. They show
that SVMs can be very sensitive to the selected optimiza-
tion method. A novel time-series approach to clinical pre-
diction is investigated by Toma et al. [22]. This hybrid
method incorporates the discovery of frequent temporal
patterns within traditional logistic regression models.
The resulting models are then used for predicting patient
mortality in critical care.3. Application domains of IDA
As evidenced by the papers in this issue, IDA techniques
can be applied to a broad base of application domains in
biomedicine. For instance, clinical applications range from
critical care (the papers by Verduijn; Toma; Guyet) to
cardiology (Metheny), pathology (Lessmann et al.), and
biosurveillance (Wallstrom and Hogan). Reﬂecting the
success of modern DNA sequencing technology, the issue
also includes a number of basic science applications of
IDA: the discovery of gene expression regulation mecha-
nisms (Sacchi et al.; Wang), analysis of biochemical signal-
ing pathways in the cell (Panteris; Dinu; Nayak), and
discovery of molecular diagnostic markers (Mahata and
Mahata). This issue is completed with an excellent review
of knowledge-based data mining methods for gene expres-
sion data by Bellazzi and Zupan [23], which complements
an earlier review on predictive data mining in clinical med-
icine by the same authors [24].4. The future of IDA in biomedicine
Knowledge discovery in databases has recovered from
a ‘‘trough of disappointment’’ that followed the initial
hype during the dot-com era of the late 1990s, and has
evolved from an activity that was carried out primarily
by academic researchers to one that is becoming part of
the mainstream business process [25]. Yet there are many
challenges that remain, especially in the biomedical ﬁeld
where large-scale electronic gathering and storage of data
have just started. With improvements in the standards for
coding and exchanging biomedical information and
knowledge, collections of molecular and clinical data will
become not only larger but especially more comprehensive
as they link heterogeneous information on a single indi-
vidual and even across entire populations of individuals.
In addition, repositories of background knowledge, as in
the form of web ontologies for example, will continue
to grow. These sources present growing challenges for
IDA researchers to develop methods that will help to
further our understanding of the complex relationships
between genetic disposition, psychosocial development,
lifestyle, medical care, and health. We hope that the
papers included in this issue will stimulate researchers
working in IDA and related disciplines to explore and
develop new methods and tools and ﬁnd new applications
for them, while encouraging those who are new to IDA to
consider it as a fruitful ﬁeld for research and practice in
biomedicine.References
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